Grifols | GRFS - Gewinn Vor Steuern

Aktienkurs
7.71
Täglich Wechseln
0.13 1.72%
Monatlich
-14.99%
Jährlich
-0.52%
Q1 Prognose
7.36




Gewinn Vor Steuern Veränderung Datum
Alaunos Therapeutics USD -7.84M 633K 2023-12
Arca Biopharma USD -29.58M 694K 2025-12
aTyr Pharma USD -25.75M 6.22M 2025-09
Bio Path USD -4.6M 1.74M 2025-06
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cara Therapeutics USD -4.91M 3.17M 2025-03
Esperion Therapeutics USD 63.67M 95M 2025-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Grifols EUR 257.85M 190.87M 2024-12
Immunic USD -21.38M 8.2M 2024-06
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Sangamo BioSciences USD -36.05M 12.94M 2024-06
TherapeuticsMD USD -1.05M 241K 2024-06